Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.330
+0.040 (3.10%)
May 3, 2024, 2:14 PM EDT - Market open

Ekso Bionics Holdings Revenue

Ekso Bionics Holdings had revenue of $17.91M in the twelve months ending March 31, 2024, with 23.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.76M, a -8.88% decrease year-over-year. In the year 2023, Ekso Bionics Holdings had annual revenue of $18.28M with 41.57% growth.

Revenue (ttm)
$17.91M
Revenue Growth
+23.82%
P/S Ratio
1.31
Revenue / Employee
$255,900
Employees
70
Market Cap
23.63M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202318.28M5.37M41.57%
Dec 31, 202212.91M1.67M14.81%
Dec 31, 202111.25M2.36M26.62%
Dec 31, 20208.88M-5.04M-36.18%
Dec 31, 201913.92M2.59M22.81%
Dec 31, 201811.33M3.98M54.11%
Dec 31, 20177.35M-6.87M-48.29%
Dec 31, 201614.22M5.56M64.20%
Dec 31, 20158.66M3.33M62.59%
Dec 31, 20145.33M2.03M61.33%
Dec 31, 20133.30M596.00K22.03%
Dec 31, 20122.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cue Health 70.94M
Exagen 52.55M
Sol-Gel Technologies 1.55M
OncoCyte 1.50M
Aptorum Group 431.38K
Bullfrog AI 65.00K
Benitec Biopharma 61.00K
Revenue Rankings